Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections
This study has been completed.
Study NCT00207753 Information provided by Centers for Disease Control and Prevention
First Received: September 13, 2005 Last Updated: November 16, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ascariasis
Trichuriasis
Hookworm Infection
Strongyloidiasis
Pediculosis
Additional conditions recognized in this trial
Communicable Diseases
Hookworm Infections
Infection
Lice Infestations
More general conditions related to this trial
Adenophorea Infections
Ascaridida Infections
Ectoparasitic Infestations
Enoplida Infections
Helminthiasis
Nematode Infections
Parasitic Diseases
Rhabditida Infections
Secernentea Infections
Skin Diseases
Skin Diseases, Infectious
Skin Diseases, Parasitic
Strongylida Infections
Additional drug interventions recognized in this trial
Albendazole
Ivermectin
More general drug interventions related to this trial
Anthelmintics
Anti-Infective Agents
Anticestodal Agents
Antimitotic Agents
Antineoplastic Agents
Antiparasitic Agents
Antiplatyhelmintic Agents
Antiprotozoal Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Centers for Disease Control and Prevention
Universidad del Valle de Guatemala
Back to top of Main Content